• Reproductive

    Genetic Testing for all your infertility issues
  • Cancer
    Genetic Testing

    Risk Assesment, Tumour Profiling and Liquid Biopsy
  • Daisy
    Non-Invasive Prenatal TestingTM

    For a peace of Mind

Welcome To Reproductive Genetics & Cancer Solutions

RGCS is one of the premium Next Generation Sequencing (NGS)-based genomics company in India. It is dedicated in providing molecular diagnostic solutions in the domains of Reproductive Genetics, Cancer Genetics, and Pharmacgenomics for personalised medicine to drive the next generation precision medicine.

Our Main Services

Daisy Non Invasive Prenatal TestTM

Available for Pregnant Moms from 10 weeks of Gestation, with Zero risk of Miscarriage

Prenatal Screening

Modern methods of biochemical analysis, especially in combination with genetic and biomarker testing, are able to provide a comprehensive answer to reveal early the cause of a disease.

Preimplantation Genetic Testing

Pre-implantation Genetic Screening and Preimplantation Genetic Diagnosis

Prenatal Diagnosis

Prenatal diagnosis determine the health of an unborn foetus. There are a variety of noninvasive and invasive techniques available for prenatal diagnosis like Chorionic villus sampling, Percutaneous umbilical blood sampling, Aminocentesis etc.

Cancer Genetic Testing

Next Generation Sequencing (NGS) Based Multi-gene Panel-Testing for Cancer Diagnosis and Targeted Treatment.


Karyotyping to R/O, Klinefelter syndrome, Turner syndrome, Xxy syndrome, Y chromosome, microdeletion testing.

Recurrent Pregnancy Loss

Chromosome analysis from product of conception for recurrent pregnancy loss.


The study of variations of DNA and RNA characteristics as related to drug response.

Genetic Counselling

Genetic counselling is a communication process, which aims to help individuals, couples and families understand and adapt to the medical, psychological, familial and reproductive implications of the genetic contribution to specific health conditions.

Dual Plus Pre-Eclampsia Screening

In prenatal diagnostics, Placental growth factor (PLGF) testing is the newest innovation in diagnos-ing pre-eclampsia, a hypertension disorder aecting 5% to 8% of pregnancies.

Complete NGS Sequencing Solutions


RGCS uses the latest and fastest DNA analysis technology to diagnose complex genetic disorders. The complete bench of all new Ion Semi-conductor based next-generation sequencers (NGS) in our lab gives unmatched speed, affordability and accuracy required for all your molecular genetic testing. Automised robotic workflows with Ion Chef System provides consistant Quality.

More Services


BRCAChekTM is a next-generation sequencing test that looks for abnormal variants in BRCA1 and BRCA2 genes. Detection of abnormal variants in either BRCA1 or BRCA2 gene significantly increases a patient's risk for breast and or ovarian cancer in females and prostate cancer in males.


10% of all prostate cancers are hereditary, meaning that an increased risk for the disease runs in the family. This next-generation sequencing test offered for men with, or at risk of prostate cancer. Test looks for abnormal variants in BRCA1, BRCA2, HOXB13, MLH1, MSH2, MSH6, PMS2 and EPCAM genes.


ColoChekTM is an NGS based Next generation Genetics test method that analyses 11 high-risk colorectal cancer genes ( EPCAM, MLH1, MSH2, MSH6, PMS2, MUTYH, APC, BMPR1A, SMAD4, PTEN and STK11) to determine genetic predisposition for the disease. Perfomred on a blood sample.